Addnok Sublingual tablet
Marketer
Rusan Pharma Ltd
Salt Composition
Buprenorphine (0.2mg)
Overview Addnok Sublingual tablet
Addnok sublingual tablets provide relief from moderate to severe pain and aid in managing opioid addiction. This medication mitigates withdrawal symptoms associated with opioid cessation. Adhere strictly to your physician's prescribed dosage and regimen. Avoid exceeding the recommended amount or frequency. Consumption may coincide with meals or be taken independently, but consistent timing is crucial. For missed doses, administer as soon as remembered unless the next dose is imminent; in that case, omit the missed dose and resume the usual schedule. Never double the dose. Commonly reported adverse effects include nausea, vomiting, dizziness, headaches, insomnia, and constipation. Other potential side effects may encompass anxiety, orthostatic hypotension (a sudden drop in blood pressure upon standing), and diarrhea. Exercise caution when operating machinery or driving due to possible drowsiness or blurred vision.
Primary Ingredients of Addnok Sublingual tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Addnok Sublingual tablet
Morphine addiction: Management of moderate to intense pain
Major Benefits of Addnok Sublingual tablet:
Allow the tablet to dissolve by positioning it either beneath your tongue or nestled between your cheek and gum. Avoid chewing, crushing, or swallowing the tablet whole. Addnok Sublingual tablets can be administered with or without food; however, consistent timing is recommended.
Common Side effects of Addnok Sublingual tablet:
- Headache
- Back pain
- Drowsiness
- Vomiting
- Insomnia (difficulty in sleeping)
- Dizziness
- Abdominal pain
- Weakness
- Sweating
- Constipation
- Withdrawal syndrome
- Infection
- Vertigo
- Inflammation of the nose
- Chills
- Flu-like symptoms
- Nausea
How to use Addnok Sublingual tablet:
Allow the tablet to dissolve by positioning it either beneath your tongue or nestled against your cheek and gum. Avoid chewing, crushing, or swallowing the tablet whole. Consumption of Addnok Sublingual tablets may coincide with meals or be taken independently; however, consistent timing is recommended.
How Addnok Sublingual tablet works:
Sublingual Addnok tablets function as a partial opioid agonist, mitigating withdrawal symptoms in individuals discontinuing opioid medications by mimicking their effects. This medication also offers analgesia through its interaction with specific brain receptors, thus modifying the body's perception and reaction to pain.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Addnok Sublingual tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Addnok Sublingual tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Addnok Sublingual tablets while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Addnok Sublingual tablets might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should use Addnok Sublingual tablets cautiously. A modified Addnok Sublingual tablet dosage may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Addnok Sublingual tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Addnok Sublingual tablets are contraindicated in patients with severe liver disease.
What if you forget to take Addnok Sublingual tablet :
NA
Facts to Know About Addnok Sublingual tablet
| Label | Value |
|---|---|
| Chemical Type | Phenanthrene Derivatives |
| Developing Habits | . |
| Treatment Category | Neuroscience and Central Nervous System |
| Behavior Class | Partial Opioid Agonists |
3,018 People bought this recently